Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endo Boosts Urology Device Presence With $2.9 Billion AMS Bid

This article was originally published in The Gray Sheet

Executive Summary

Endo Pharmaceuticals has made its second big jump into the urology device space in less than a year, announcing April 11 that it will pay $2.9 billion in cash for American Medical Systems.

You may also be interested in...



Endo Unit Shutdown Could Strand Incontinence Treatment Praised By FDA Panel

Endo International plans to shutter its Astora Women's Health business unit – formerly part of American Medical Systems – this month due to ongoing legal concerns tied to the company’s vaginal mesh products. What’s unclear is what this means for the company’s investigational fecal incontinence treatment, which received unanimous support from an FDA advisory panel just days before the shutdown was announced.

Boston Sci Ups Urology Focus With $1.6 Billion AMS Deal

The firm is expanding its leadership position in the urology space with its acquisition of American Medical Systems's men's health and prostate health units.

People In Brief

Endo Health Systems names president of American Medical Systems subsidiary. MAKO Surgical Senior VP of Sales & Marketing resigns. More people briefs.

Related Content

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel